I agree that this site is using cookies. You can find further informations here.
X
Elishmereni, Moran
16  results:
Search for persons X
?
1

Mathematical model of hormone sensitive prostate cancer tre..:

Foryś, Urszula ; Nahshony, Alon ; Elishmereni, Moran.
PLOS ONE.  17 (2022)  2 - p. e0263648 , 2022
Link: https://doi.org/10.1371/..
 
?
2

Accelerating the Development of Personalized Cancer Immunot..:

Agur, Zvia ; Elishmereni, Moran ; Foryś, Urszula.
Clinical Pharmacology & Therapeutics.  108 (2020)  3 - p. 515-527 , 2020
Link: https://doi.org/10.1002/..
 
?
3

Predicting time to castration resistance in hormone sensiti..:

Elishmereni, Moran ; Kheifetz, Yuri ; Shukrun, Ilan...
The Prostate.  76 (2015)  1 - p. 48-57 , 2015
Link: https://doi.org/10.1002/..
 
?
4

Complex pattern of interleukin-11-induced inflammation reve..:

Kheifetz, Yuri ; Elishmereni, Moran ; Agur, Zvia
Journal of Pharmacokinetics and Pharmacodynamics.  41 (2014)  5 - p. 479-491 , 2014
Link: https://doi.org/10.1007/..
 
?
5

Personalizing oncology treatments by predicting drug effica..:

Agur, Zvia ; Elishmereni, Moran ; Kheifetz, Yuri
WIREs Systems Biology and Medicine.  6 (2014)  3 - p. 239-253 , 2014
Link: https://doi.org/10.1002/..
 
?
6

An Integrated Disease/Pharmacokinetic/Pharmacodynamic Model..:

Elishmereni, Moran ; Kheifetz, Yuri ; Søndergaard, Henrik...
PLoS Computational Biology.  7 (2011)  9 - p. e1002206 , 2011
Link: https://doi.org/10.1371/..
 
?
7

CD48: A co-stimulatory receptor of immunity:

Elishmereni, Moran ; Levi-Schaffer, Francesca
The International Journal of Biochemistry & Cell Biology.  43 (2011)  1 - p. 25-28 , 2011
Link: https://doi.org/10.1016/..
 
?
8

Predicting Outcomes of Prostate Cancer Immunotherapy by Per..:

Kronik, Natalie ; Kogan, Yuri ; Elishmereni, Moran...
PLoS ONE.  5 (2010)  12 - p. e15482 , 2010
Link: https://doi.org/10.1371/..
 
?
9

Ultrastructural evidence for human mast cell-eosinophil int..:

Minai-Fleminger, Yael ; Elishmereni, Moran ; Vita, Francesca...
Cell and Tissue Research.  341 (2010)  3 - p. 405-415 , 2010
Link: https://doi.org/10.1007/..
 
?
10

Optimization of interleukin-21 immunotherapeutic strategies:

Cappuccio, Antonio ; Elishmereni, Moran ; Agur, Zvia
Journal of Theoretical Biology.  248 (2007)  2 - p. 259-266 , 2007
Link: https://doi.org/10.1016/..
 
?
11

Fluid‐Retention Side‐Effects of the Chemotherapy‐Supportive..:

Kheifetz, Yuri ; Elishmereni, Moran ; Horowitz, Smadar.
Computational and Mathematical Methods in Medicine.  7 (2000)  2-3 - p. 71-84 , 2000
Link: https://doi.org/10.1080/..
 
?
12

Mathematical model of hormone sensitive prostate cancer tre..:

Urszula Foryś ; Alon Nahshony ; Moran Elishmereni
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8846544/?tool=EBI.  , 2022
Link: https://doaj.org/article..
 
?
13

Mathematical model of hormone sensitive prostate cancer tre..:

Urszula Foryś ; Alon Nahshony ; Moran Elishmereni
https://doi.org/10.1371/journal.pone.0263648.  , 2022
Link: https://doi.org/10.1371/..
 
?
14

An integrated disease/pharmacokinetic/pharmacodynamic model..:

Moran Elishmereni ; Yuri Kheifetz ; Henrik Søndergaard..
http://europepmc.org/articles/PMC3182868?pdf=render.  , 2011
Link: https://doi.org/10.1371/..
 
?
15

Predicting outcomes of prostate cancer immunotherapy by per..:

Natalie Kronik ; Yuri Kogan ; Moran Elishmereni...
http://europepmc.org/articles/PMC2999571?pdf=render.  , 2010
Link: https://doi.org/10.1371/..
 
1-15